Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Maxpar Human Immune Monitoring Panel Kit

Fluidigm has launched the Maxpar Human Immune Monitoring Panel Kit for comprehensive immune cell profiling in cancer and immune-mediated diseases. Designed for use with the company's Helios CyTOF mass cytometry system, the new kit contains 29 metal-labeled antibodies and reagents designed and optimized for deep immune profiling of human peripheral blood mononuclear cells in a single tube. The panel biomarkers were selected in collaboration with pharmaceutical companies and academic institutions, and are optimized for routine high-parameter immune profiling, Fluidigm said. Multiple third-party data-analysis options are available to analyze results from the panel, including Cytobank and GemStone software. Verity Software House is providing free access to an enhanced version of GemStone software to customers who purchase the kit.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.